# Lyell Immunopharma (LYEL) — Analyst Forecast

LYEL · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/lyel/forecast

## Analyst consensus

| Consensus | Buy | Hold | Sell | Analysts |
| --- | --- | --- | --- | --- |
| Buy | 6 | 0 | 1 | 7 |

## Price target

| Low | Average | High | Analysts |
| --- | --- | --- | --- |
| $36.00 | $41.33 | $44.00 | 3 |

Last price $8.19 (as of Oct 16, 2026).

## Recent analyst ratings

| Date | Firm | Action | Rating | Price target |
| --- | --- | --- | --- | --- |
| Sep 11, 2026 | Needham | Maintained | Buy | $44.00 |
| Aug 6, 2026 | Stifel | Initiated Coverage | Buy | $36.00 |
| Jul 22, 2026 | B. Riley Securities | Initiated Coverage | Buy | $44.00 |
| Jun 15, 2026 | Needham | Maintained | Buy | $44.00 |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | $34.00 |
| Jun 9, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| Jun 8, 2026 | Needham | Maintained | Buy | $44.00 |
| Jun 3, 2026 | HC Wainwright & Co. | Maintained | Buy | $45.00 |
| May 7, 2026 | Needham | Maintained | Buy | $44.00 |
| Apr 10, 2026 | Needham | Initiated Coverage | Buy | $44.00 |
| Mar 9, 2026 | Citizens | Initiated Coverage | Market Outperform | $34.00 |
| Dec 9, 2025 | HC Wainwright & Co. | Upgraded | Neutral → Buy | $45.00 |
| Nov 24, 2025 | HC Wainwright & Co. | Maintained | Neutral | $20.00 |
| Sep 26, 2025 | LUCID CAPITAL MARKETS | Initiated Coverage | Buy | $20.00 |
| Jun 24, 2025 | HC Wainwright & Co. | Maintained | Neutral | $10.00 |
| Apr 16, 2025 | HC Wainwright & Co. | Maintained | Neutral | $1.00 |
| Mar 13, 2025 | HC Wainwright & Co. | Maintained | Neutral | $1.00 |
| Nov 12, 2024 | HC Wainwright & Co. | Maintained | Neutral | $1.00 |
| Oct 30, 2024 | B of A Securities | Downgraded | Buy → Underperform | $1.00 |
| Oct 28, 2024 | HC Wainwright & Co. | Maintained | Neutral | $1.00 |

## Frequently Asked Questions

### What is the price target for LYEL stock?

The average 12-month analyst price target for Lyell Immunopharma (LYEL) is $41.33, with a high estimate of $44.00 and a low of $36.00, across 3 analysts.

### Is LYEL a buy, sell, or hold?

Analysts covering Lyell Immunopharma currently average a Buy rating: 6 buy, 0 hold and 1 sell, from 7 analysts. Ratings reflect analyst opinion, not investment advice.

### What upside do analysts see for LYEL?

The average price target of $41.33 implies 404.68% upside from the last price of $8.19.

### What is the latest analyst rating on LYEL?

On Sep 11, 2026, Needham maintained Lyell Immunopharma at Buy with a price target of $44.00.

---

Analyst ratings and price targets are the opinions of third-party research firms, not of Light Horse Securities. They are estimates about an uncertain future, are frequently wrong, and are neither a recommendation nor a prediction of actual results.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).